A patient with recently diagnosed psoriatic arthritis is being counseled on lifestyle modifications to manage his condition effectively. Which recommendation should the nurse prioritize to reduce the risk of exacerbating joint symptoms?

B) Follow a balanced diet to maintain a healthy weight.

A) Engage in high-impact exercises to strengthen muscles.

B) Follow a balanced diet to maintain a healthy weight.

C) Increase salt intake to improve joint fluid retention.

D) Prolong periods of rest to minimize joint stress.

A patient with psoriatic arthritis is experiencing significant joint pain and stiffness, which affects their quality of life and work capabilities. The healthcare team is considering starting a disease-modifying antirheumatic drug (DMARD). What is the primary goal of initiating a DMARD in this patient?

B) To reduce inflammation and slow disease progression

A) To completely cure the psoriatic arthritis

B) To reduce inflammation and slow disease progression

C) To immediately relieve joint pain and stiffness

D) To enhance the patient's immune response against the disease

A patient on methotrexate therapy for rheumatoid arthritis reports increased fatigue and shortness of breath. Recent lab results show a drop in hemoglobin levels. As the nurse, what is the most appropriate initial intervention?

C) Administer prescribed folic acid supplementation

A) Educate the patient about increasing dietary iron intake

B) Instruct the patient to stop methotrexate immediately

C) Administer prescribed folic acid supplementation

D) Recommend over-the-counter iron supplements

A patient with rheumatoid arthritis has been started on methotrexate therapy. During a follow-up visit, the patient reports increased fatigue and shortness of breath. Laboratory results show a drop in hemoglobin levels and mildly elevated liver enzymes. Which nursing intervention is the priority in managing this patient?

D) Assess the patient for additional signs of liver dysfunction and notify the healthcare provider.

A) Educate the patient on the importance of adherence to methotrexate therapy.

B) Monitor the patient for further signs of bleeding and increased bruising.

C) Encourage the patient to increase dietary iron intake to address anemia.

D) Assess the patient for additional signs of liver dysfunction and notify the healthcare provider.

A patient on methotrexate for psoriasis reports new symptoms of abdominal discomfort and mild nausea. Recent lab results show elevated liver enzymes. Which nursing intervention is most appropriate to support liver health and address these symptoms?

B) Advise the patient to consume a diet rich in fruits and vegetables and avoid alcohol.

A) Encourage the patient to increase protein intake to aid liver repair.

B) Advise the patient to consume a diet rich in fruits and vegetables and avoid alcohol.

C) Suggest the patient increase fluid intake to flush out toxins from the liver.

D) Recommend the patient take over-the-counter antacids to relieve abdominal symptoms.

A 55-year-old male patient with a history of psoriasis is experiencing mild nausea and abdominal discomfort following methotrexate dose reduction and folic acid supplementation. Recent lab results indicate elevated liver enzymes. Which nursing intervention is most appropriate to prioritize in this scenario?

B) Advise the patient to avoid alcohol and other hepatotoxic substances.

A) Encourage the patient to increase dietary protein to support liver healing.

B) Advise the patient to avoid alcohol and other hepatotoxic substances.

C) Suggest the patient increase intake of high-fiber foods to enhance liver function.

D) Instruct the patient to increase fluid intake to aid in the elimination of toxins.

A patient with psoriasis and mild fatty liver changes due to methotrexate therapy reports new joint discomfort. Which nursing intervention is most appropriate to address the patient's joint symptoms while considering his liver condition?

C) Recommend the application of warm compresses to the affected joints.

A) Advise the patient to increase physical activity to alleviate joint stiffness.

B) Suggest the use of over-the-counter NSAIDs to manage joint pain.

C) Recommend the application of warm compresses to the affected joints.

D) Encourage the patient to increase dietary calcium and vitamin D intake.

A patient with a known history of psoriasis and recent findings of mild fatty liver changes attributed to methotrexate use now presents with joint discomfort in the knees and elbows. What is the nurse's priority action in managing this patient's new symptom?

C) Notify the healthcare provider to consider alternative therapies for psoriatic arthritis.

A) Increase the patient's methotrexate dosage to address the psoriatic arthritis symptoms.

B) Educate the patient on the importance of maintaining a low-fat diet and avoiding alcohol.

C) Notify the healthcare provider to consider alternative therapies for psoriatic arthritis.

D) Advise the patient to use over-the-counter NSAIDs for joint pain relief without further assessment.

A patient with newly diagnosed early psoriatic arthritis is being considered for a disease-modifying antirheumatic drug (DMARD) to prevent joint damage. Which nursing intervention is most important in the initial management of this patient?

B) Educate the patient on the importance of adhering to low-impact exercises.

A) Monitor liver function tests regularly while on methotrexate.

B) Educate the patient on the importance of adhering to low-impact exercises.

C) Schedule regular follow-up appointments to monitor treatment response.

D) Discuss dietary modifications to reduce inflammation.

A patient with suspected psoriatic arthritis has been referred to a rheumatologist. The nurse is preparing to educate the patient about managing their symptoms at home. Which of the following interventions should the nurse emphasize to help reduce joint discomfort and prevent progression of the disease?

B) Recommend the use of disease-modifying antirheumatic drugs (DMARDs) and regular follow-up

A) Encourage high-impact exercises to strengthen the joints

B) Recommend the use of disease-modifying antirheumatic drugs (DMARDs) and regular follow-up

C) Advise on maintaining a sedentary lifestyle to minimize joint stress

D) Suggest applying heat packs to reduce inflammation and swelling

Psoriasis - Nursing Case Study

Pathophysiology

• Primary mechanism: Psoriasis is primarily driven by an overactive immune response, where T-cells mistakenly attack healthy skin cells. This triggers an inflammatory cascade, leading to rapid skin cell proliferation and accumulation.

• Secondary mechanism: The hyperproliferation of keratinocytes results in accelerated skin cell turnover, causing the buildup of thick, scaly plaques on the skin surface. This disrupts normal skin barrier function and contributes to the visible symptoms.

• Key complication: Chronic inflammation in psoriasis can extend beyond the skin, potentially leading to systemic issues, including psoriatic arthritis and increased cardiovascular risk, highlighting the importance of comprehensive patient management.

Patient Profile

Demographics:

45-year-old male, construction worker

History:

• Key past medical history: History of mild psoriasis for 10 years, hypertension

• Current medications: Topical corticosteroids, lisinopril

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Worsening skin lesions and joint pain

• Key symptoms: Extensive red, scaly patches on the skin, pain and swelling in joints, fatigue

• Vital signs: Blood pressure 150/95 mmHg, heart rate 92 bpm, respiratory rate 20 breaths per minute, temperature 37.8°C

Section 1

As the clinical team delves deeper into the patient's case, further assessment reveals significant findings that suggest the progression of psoriatic arthritis. A detailed musculoskeletal examination shows marked swelling and tenderness in the distal interphalangeal joints of both hands and moderate swelling in the knees. The patient reports morning stiffness lasting over an hour, which gradually improves throughout the day but returns with any prolonged activity. These symptoms, combined with his current skin condition, pose a challenge in effectively managing his daily responsibilities as a construction worker, impacting his quality of life and ability to work.

Laboratory investigations are subsequently ordered to evaluate the extent of systemic inflammation and potential joint damage. The patient's erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels are significantly elevated, indicating active inflammation. Additionally, imaging studies, including X-rays of the hands and knees, reveal early erosive changes consistent with psoriatic arthritis, further supporting the diagnosis. These findings prompt the healthcare team to consider modifying the patient's treatment regimen to address both his skin and joint symptoms more comprehensively.

With the updated clinical picture, the healthcare team discusses the importance of initiating a systemic treatment approach to manage the underlying inflammatory process and prevent further joint damage. The patient is counseled on the potential benefits of adding a disease-modifying antirheumatic drug (DMARD) or a biologic agent to his regimen. The team emphasizes the need for regular follow-up and monitoring for potential side effects, as well as the importance of lifestyle modifications to manage his hypertension and reduce cardiovascular risks associated with chronic inflammation. As the patient begins this new treatment plan, ongoing assessment will be critical to evaluate his response and adjust therapy as needed.

Section 2

As the patient embarks on the new treatment regimen, which now includes methotrexate, a DMARD, the clinical team closely monitors for any changes in his condition. Over the next several weeks, the patient reports some improvement in morning stiffness and a slight reduction in joint swelling, indicating a positive initial response to the medication. However, during a routine follow-up visit, the patient mentions experiencing increased fatigue and occasional shortness of breath during moderate physical activity, which raises concerns about potential side effects or new complications.

A comprehensive assessment is conducted, revealing that the patient's blood pressure remains well-controlled, but a significant drop in hemoglobin levels is noted, with a current reading of 9.5 g/dL compared to a previous measurement of 13.0 g/dL. This anemia prompts further investigation to rule out methotrexate-induced myelosuppression or other underlying causes. Additionally, liver function tests are ordered, given the hepatotoxic potential of methotrexate, and results show a mild elevation in liver enzymes, suggesting the need for careful monitoring and possible adjustment of the treatment plan.

In response to these findings, the healthcare team decides to temporarily reduce the methotrexate dose and initiate folic acid supplementation to mitigate hematological side effects. They also educate the patient on recognizing signs of anemia and hepatic dysfunction, emphasizing the importance of reporting any persistent or worsening symptoms. The team schedules more frequent follow-up appointments to closely monitor the patient's lab values and overall response, ensuring that both his skin and joint symptoms continue to improve without compromising his safety. This vigilant approach will allow for timely interventions and adjustments to the treatment strategy as needed, ultimately aiming to enhance the patient's quality of life and functional abilities.

Section 3

Two weeks after the methotrexate dose reduction and initiation of folic acid supplementation, the patient returns for a follow-up appointment. During the visit, he reports a modest improvement in energy levels and less frequent episodes of shortness of breath, suggesting a positive response to the interventions. However, he also mentions experiencing new symptoms of abdominal discomfort and mild nausea, which have been intermittent over the past several days. Vital signs are stable, with blood pressure reading at 120/78 mmHg and heart rate at 78 bpm. Physical examination reveals mild tenderness in the right upper quadrant of the abdomen but no palpable hepatomegaly or splenomegaly.

The clinical team reviews recent laboratory results, noting a slight improvement in hemoglobin levels, now at 10.2 g/dL, indicating a gradual recovery from anemia. However, liver function tests show a further increase in liver enzyme levels, with AST at 55 U/L and ALT at 62 U/L, both slightly above the upper limit of normal. These findings raise concerns about potential methotrexate-related hepatotoxicity, compounded by the patient's recent gastrointestinal symptoms. As a result, the healthcare team considers further modification of the treatment regimen, including the possibility of additional hepatoprotective strategies or alternative therapies for psoriasis management.

To address these developments and prevent further complications, the team emphasizes the importance of dietary modifications to support liver health and advises the patient to avoid alcohol and hepatotoxic substances. They also schedule an abdominal ultrasound to assess liver structure and rule out any significant anatomical changes. By maintaining close communication and promptly adjusting the care plan, the team aims to continue managing the patient's psoriasis effectively while safeguarding his overall health, setting the stage for ongoing evaluation and adaptation of his treatment strategy.

Section 4

A week after the abdominal ultrasound, the patient returns for another follow-up appointment, and the clinical team reviews the new diagnostic results. The ultrasound reveals mild fatty liver changes, but no significant fibrosis or cirrhosis. These findings correlate with the earlier liver function tests and provide further evidence of methotrexate-related hepatotoxicity. In light of these results, the team decides to adjust the treatment plan by reducing the methotrexate dosage even further and incorporating a hepatoprotective agent, such as silymarin, to support liver function. The patient is also advised to maintain a low-fat diet and continue avoiding alcohol and other hepatotoxic substances.

During the follow-up visit, the patient reports that the abdominal discomfort and nausea have diminished somewhat since the dietary changes, suggesting a positive response to the dietary interventions. However, he mentions experiencing a new symptom: mild joint discomfort in his knees and elbows, which has gradually developed over the past few days. Given this new development, the team is concerned about the possibility of psoriatic arthritis, a known complication of psoriasis. They decide to conduct further evaluations, including a complete blood count and inflammatory marker tests, to assess the underlying cause of the joint pain.

The team recognizes the complexity of managing multiple interrelated conditions and emphasizes the importance of ongoing monitoring and assessment. By closely tracking the patient's symptoms and laboratory results, they aim to prevent further complications and optimize the treatment strategy. The immediate goal is to address the emerging joint symptoms while continuing to manage the liver health and psoriasis, ensuring a comprehensive and coordinated approach to the patient's care.

Section 5

During the follow-up visit, the clinical team performs a thorough initial assessment to evaluate the new symptoms of joint discomfort. The patient's vital signs remain stable with a blood pressure of 120/80 mmHg, heart rate of 78 beats per minute, and temperature at 98.6°F. Physical examination reveals mild swelling and tenderness in the knees and elbows, with a reduced range of motion due to discomfort. There is no significant erythema or warmth, which might have indicated an acute inflammatory process. The patient rates his pain at a 4 on a scale of 10, which is manageable with over-the-counter analgesics.

The laboratory results return, providing further insight into the patient's condition. The complete blood count is unremarkable, but the inflammatory markers show a slight elevation, with a C-reactive protein (CRP) level of 15 mg/L (normal <10 mg/L) and an erythrocyte sedimentation rate (ESR) of 25 mm/hr (normal <20 mm/hr). These findings suggest a mild inflammatory process, consistent with early psoriatic arthritis. The team decides to refer the patient to a rheumatologist for further evaluation and to consider modifying the treatment regimen to include a disease-modifying antirheumatic drug (DMARD) that is less hepatotoxic than methotrexate, such as sulfasalazine or leflunomide.

Given the potential for psoriatic arthritis to progress, the clinical team emphasizes the importance of early intervention to prevent joint damage. They educate the patient on lifestyle modifications that could alleviate symptoms, such as engaging in low-impact exercises and maintaining a healthy weight. The team plans for regular follow-up appointments to monitor the patient's response to the new treatment regimen and to adjust the therapeutic approach as necessary, ensuring a coordinated effort in managing the psoriasis, liver health, and emerging joint issues.